Empty IV Bags

Global Empty IV Bags Market to Reach US$16.5 Billion by 2030

The global market for Empty IV Bags estimated at US$10.4 Billion in the year 2024, is expected to reach US$16.5 Billion by 2030, growing at a CAGR of 8.1% over the analysis period 2024-2030. PVC, one of the segments analyzed in the report, is expected to record a 9.1% CAGR and reach US$12.5 Billion by the end of the analysis period. Growth in the Non-PVC segment is estimated at 5.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$2.8 Billion While China is Forecast to Grow at 12.8% CAGR

The Empty IV Bags market in the U.S. is estimated at US$2.8 Billion in the year 2024. China, the world`s second largest economy, is forecast to reach a projected market size of US$3.6 Billion by the year 2030 trailing a CAGR of 12.8% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 4.0% and 7.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 5.4% CAGR.

Global Empty IV Bags Market – Key Trends & Drivers Summarized

Why Are Empty IV Bags Essential in Modern Healthcare?

Empty IV (intravenous) bags are a fundamental component of hospital and clinical healthcare settings, used for administering fluids, medications, blood transfusions, and nutrient solutions to patients. These bags serve as sterile, flexible containers that allow precise dosing and controlled infusion of medical solutions, making them indispensable in hospitals, ambulatory surgical centers, and emergency care units. The increasing demand for parenteral nutrition, IV therapy, and chemotherapy drug administration has fueled market growth, as healthcare facilities require reliable, contamination-free, and cost-effective IV solutions.

One of the key factors driving the adoption of empty IV bags is the rising prevalence of chronic diseases such as cancer, diabetes, and gastrointestinal disorders, which often require long-term IV fluid therapy. Additionally, the growing number of surgical procedures worldwide has increased the need for intravenous medication delivery, further boosting demand for IV bags. As patient safety and infection control become top priorities in healthcare, manufacturers are developing BPA-free, PVC-free, and DEHP-free IV bags to minimize contamination risks and enhance biocompatibility. With innovations in multi-chamber IV bags for advanced drug delivery, the market continues to evolve, catering to the diverse needs of modern medical treatments.

What Are the Latest Innovations in IV Bag Manufacturing?

The IV bag market has seen significant technological advancements, particularly in material innovation and drug compatibility. One of the most important developments is the shift toward non-PVC IV bags, which are free from harmful plasticizers such as DEHP (diethylhexyl phthalate). These eco-friendly IV bags are gaining popularity due to their lower toxicity levels, reduced environmental impact, and improved drug stability. Additionally, multi-compartment IV bags have been introduced, allowing for the simultaneous administration of multiple drug formulations without mixing until the point of infusion, improving medication efficiency.

Automated IV bag filling and sterilization technologies have also enhanced the safety and production efficiency of IV bags. Self-collapsing IV bags, which minimize air contamination during infusion, are being increasingly adopted in chemotherapy and parenteral nutrition applications. Furthermore, advancements in smart IV bags with integrated sensors for fluid level monitoring, temperature regulation, and automated dosage control are transforming IV therapy management in hospitals. As sustainability concerns grow, manufacturers are developing biodegradable and recyclable IV bags, reducing medical waste while maintaining sterility and durability.

Which Healthcare Sectors Are Driving Demand for Empty IV Bags?

The hospital and emergency care sector represents the largest consumer of IV bags, as patients undergoing surgeries, critical care, and trauma recovery require constant fluid administration and medication infusion. Ambulatory surgical centers and home healthcare services are also significant drivers, as outpatient and home-based IV therapy gain popularity due to cost-effectiveness and convenience.

The oncology sector is another major consumer, as chemotherapy treatments often rely on IV infusion for drug delivery. Similarly, the rising incidence of gastrointestinal disorders, kidney diseases, and severe dehydration cases has fueled demand for IV fluid therapy in healthcare settings. The pharmaceutical and biopharmaceutical industries also use IV bags in drug compounding and sterile medication preparation, further expanding market demand.

What Is Driving the Growth of the Empty IV Bags Market?

The growth in the empty IV bags market is driven by the increasing prevalence of chronic diseases, rising demand for advanced IV therapy, and innovations in material science. The shift toward non-toxic, eco-friendly IV bags has expanded the market, as healthcare facilities prioritize patient safety and sustainability. The expansion of home-based IV therapy has further fueled demand for compact, easy-to-use IV bags.

The rise in surgical procedures, emergency care admissions, and chemotherapy treatments has led to increased production and distribution of IV bags. Additionally, the integration of smart IV bag technology, improved drug compatibility, and sustainable packaging solutions has propelled market growth. As healthcare infrastructure expands globally, the IV bag market is set for continued innovation and adoption, ensuring efficient and safe patient care delivery.

SCOPE OF STUDY:

The report analyzes the Empty IV Bags market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:
Product (PVC, Non-PVC)

Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 41 Featured) -

• B. Braun Medical Inc.
• BAUSCH Advanced Technology Group
• Baxter International Inc.
• BD (Becton, Dickinson and Company)
• Epic Medical
• Fresenius Kabi AG
• Haemotronic
• ICU Medical, Inc.
• JW Life Science Corp
• Kraton Corporation
• Krishna Meditech
• Medline Industries, LP
• Merit Healthcare
• Otsuka Pharmaceutical India Private Limited
• POLYCINE GmbH
• RENOLIT SE
• Sippex IV Bag
• Technoflex
• Vonco Products
• Wipak Group

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA
CHINA
MEXICO
CANADA
EU
JAPAN
INDIA
176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.